latest tirzepatide news New clinical trial: Zepbound (tirzepatide) helped adults lose an average of 20.2% of their body weight—around 50 lbs—over 72 weeks, outperforming Wegovy's 13.7% (~33 lbs). Credit to: https://www.healthline.com/health-news/zepbound-wegovy-weight-loss Latest news: Tirzepatide for type

Chemical strategies for half-life extension of biopharmaceuticals: Lipidation and its alternatives

In our extensive nationwide population study, we did not observe an increased risk of developing all thyroid cancers, including MTC, in patients with T2DM treated with GLP-1 RAs compared to those not receiving these agents

Acetyl-L-Carnitine (ALCAR)

Peptides are fragile molecules that degrade when exposed to heat, light, moisture, and contamination

But now youre dealing with burps that smell like rotten eggs and youre starting to think that better health is overrated

There are side effects to Wegovy, like any medicine, including gallbladder issues, risk of low blood sugar, and stomach problems, to name a few.